Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NZE/RUA stock hub

NZE/RUA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NZE/RUAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
10.1M
New Zealand Stock Exchange
Market data

Price

Recent price action with selectable time range.

NZE/RUANZE/RUA
—
Loading chart…
In the news

Latest news · NZE/RUA

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-56.9
P25 n/aP50 n/aP75 n/a
ROIC-29.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NZE/RUA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
175
Groups with data
11
Currency
NZD
Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
New Zealand
Country code
NZ
Enterprise value
NZD 9.8M
Exchange
New Zealand Stock Exchange
Financial currency
NZD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
NZRUAE0004S1
Last refreshed
2026-05-10
Market cap
NZD 10.1M
Price
NZD 0.03
Price currency
NZD
Sector
Healthcare
Sic
2833
Symbol
nze/RUA
Website
https://www.ruabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-33.99%
EV Earnings
-2.84x
EV/FCF
-4.13x
EV/Sales
4.09x
FCF yield
-23.35%
P/B ratio
1.74x
P/S ratio
4.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-141.84%
EBITDA Margin
-127.63%
Gross margin
41.88%
Gross Profit
NZD 1M
Gross Profit Growth
17.88%
Gross Profit Growth Q
37.75%
Gross Profit Growth3 Y
107.47%
Gross Profit Growth5 Y
24.96%
Net Income
NZD -3.4M
Net Income Growth Quarters
4%
Net Income Growth Years
1%
Pretax Margin
-144.06%
Profit Margin
-144.06%
ROA
-25.83
Roa5y
-19.03
ROCE
-57.75
ROE
-56.91
Roe5y
-48.25
ROIC
-29.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
2.76%
Cagr3y
-43.12%
Cagr5y
-39.25%
EPS Growth Quarters
4
EPS Growth Years
1
Revenue Growth
124.84x
Revenue Growth Q
63.66x
Revenue Growth Quarters
3x
Revenue Growth Years
1x
Revenue Growth3 Y
96.29x
Revenue Growth5 Y
29.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
NZD 0.29
Assets
NZD 8.7M
Cash
NZD 2.2M
Current Assets
NZD 4.5M
Current Liabilities
NZD 2.8M
Debt
NZD 1.8M
Debt Equity
NZD 0.31
Debt FCF
NZD -0.77
Equity
NZD 5.8M
Interest Coverage
-11.89
Liabilities
NZD 2.9M
Long Term Assets
NZD 4.2M
Long Term Liabilities
NZD 31,496
Net Cash
NZD 353,399
Net Cash By Market Cap
NZD 3.48
Net Cash Growth
1,263.69%
Net Debt Equity
NZD -0.06
Tangible Book Value
NZD 3.6M
Tangible Book Value Per Share
NZD 0.01
WACC
7.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.58
Inventory Turnover
2.77
Net Working Capital
NZD 1.2M
Quick ratio
0.9
Working Capital
NZD 1.6M
Working Capital Turnover
NZD 1.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-62.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
2.75%
200-day SMA
0.04
3Y total return
-81.6%
50-day SMA
0.03
50-day SMA vs 200-day SMA
50under200
5Y total return
-91.72%
All Time High
0.75
All Time High Change
-96%
All Time High Date
2020-10-22
All Time Low
0.02
All Time Low Change
30.43%
All Time Low Date
2024-12-09
ATR
0
Beta
0.49
Beta1y
0.82
Beta2y
0.76
Ch YTD
7.14
High
0.03
High52
0.06
High52 Date
2025-09-05
High52ch
-49.15%
Low
0.03
Low52
0.02
Low52 Date
2025-06-24
Low52ch
25%
Ma50ch
-5.96%
Price vs 200-day SMA
-18.26%
RSI
37.8
RSI Monthly
33.03
RSI Weekly
44.43
Sharpe ratio
0.32x
Sortino ratio
0.6
Total Return
-62.31%
Tr YTD
7.14
Tr1m
-11.76%
Tr1w
3.45%
Tr3m
-9.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
NZD -3.4M
Operating margin
-141.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
222,814,446%
Net Borrowing
1,076,147
Shares Insiders
26.96%
Shares Institutions
2.5%
Shares Out
338,041,705
Shares Qo Q
32.54%
Shares Yo Y
62.31%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
NZD -2.4M
Average Volume
31,996.9x
Bv Per Share
0.02
CAPEX
NZD -3,431
Ch1m
-11.76
Ch1w
3.45
Ch3m
-9.09
Ch3y
-84.85
Ch5y
-93.18
Ch6m
7.14
Change
0%
Change From Open
0
Close
0.03
Days Gap
0
Depreciation Amortization
339,952
Dollar Volume
107.5
Earnings Date
2026-05-28
EBIT
NZD -3.4M
EBITDA
NZD -3.1M
EPS
NZD -0.01
F Score
3
FCF
NZD -2.4M
FCF EV Yield
-24.2x
FCF Per Share
NZD -0.01
Financing CF
3,864,664
Fiscal Year End
June
Founded
2,016
Goodwill
2,194,947
Investing CF
106,266
Is Primary Listing
1
Last Earnings Date
2026-02-26
Last Report Date
2025-12-31
Ma150
0.03
Ma150ch
-7.98%
Ma20
0.03
Ma20ch
-2.6%
Net CF
1,627,644
Next Earnings Date
2026-05-28
Open
0.03
Ppne
1,978,627
Price Date
2026-05-08
Ptbv Ratio
2.78
Relative Volume
0.11x
Revenue
2,392,676x
SBC By Revenue
1.75x
Share Based Comp
41,782
Tr6m
7.14%
Volume
3,582
Z Score
-6.02
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NZE/RUA pay a dividend?

Capital-return profile for this ticker.

Performance

NZE/RUA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+2.8%
S&P 500 1Y: n/a
3Y total return
-81.6%
S&P 500 3Y: n/a
5Y total return
-91.7%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NZE/RUA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+2.5%
Share of float held by funds and institutions
Insider ownership
+27.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+62.3%
Negative means the company is buying back shares.
Technical

NZE/RUA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
37.8
Neutral momentum band
Price vs 200-day MA
-18.3%
50/200-day relationship not available
Beta (5Y)
0.49
Less volatile than the market
Sharpe ratio
0.32
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NZE/RUA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nze/RUA stock rating?

nze/RUA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nze/RUA analysis?

The full report lives at /stocks/nze/RUA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nze/RUA?

The latest report frames nze/RUA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nze/RUA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.